Expression of SPAG9 in epithelial ovarian, breast, cervix, and thyroid cancer, as well as in renal cell and colorectal carcinoma was linked to tumor progression and migration [40], whereas the role of SPAG9 in prostate cancer remained unknown. This evidence concerns the gene SPAG9 and neoplasm.